4/A: Tredegar Corp Executive John M. Steitz Amends SEC Filing to Correct Stock Grant

John M. Steitz, President and CEO of Tredegar Corp, files an amended SEC Form 4 to correct a previously reported stock grant due to exceeding the calendar year limit.

Summary

• John M. Steitz, President and CEO of Tredegar Corp, filed an amended SEC Form 4 on March 21, 2024, to correct a previous filing from May 6, 2022.
• The amendment addresses an error in the number of restricted stock shares granted on May 4, 2022.
• The original filing incorrectly stated that 83,652 shares were granted, but the correct amount is 75,000 shares.
• The error occurred because the initial grant exceeded the calendar year limit imposed by the Tredegar Corporation Amended and Restated 2018 Equity Incentive Plan by 8,652 shares.
• The excess shares were deemed null and void.
• Following the corrected transaction, Steitz beneficially owns 182,287 shares of Tredegar Common Stock.

Sentiment

Score: 6

Explanation: The document is a routine correction of a previous filing. While the initial error is a minor negative, the correction itself is a positive sign of compliance.

Negatives

• The initial stock grant exceeded the allowable limit under the company's equity incentive plan, indicating a potential oversight in the grant process.

Risks

• Errors in reporting and compliance with equity incentive plans could lead to regulatory scrutiny or reputational damage.

Industry Context

SEC Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with securities regulations.

Comparison to Industry Standards

• Equity compensation is a common practice among publicly traded companies to align management's interests with those of shareholders.
• The Tredegar Corporation Amended and Restated 2018 Equity Incentive Plan is similar to those of other companies such as Alcoa, Ball Corporation, and Crown Holdings, Inc., which also use equity-based compensation to incentivize executives.
• The vesting schedule of the restricted stock (March 21, 2025) is a typical vesting period, similar to those used by other companies in the materials and manufacturing sectors.

Stakeholder Impact

• The correction of the stock grant ensures accurate reporting and transparency for shareholders.

Key Dates